**Core Concept**
Direct thrombin inhibitors (DTIs) are a class of anticoagulant medications that directly inhibit the activity of thrombin, a key enzyme in the coagulation cascade. They are used to prevent and treat thrombotic disorders.

**Why the Correct Answer is Right**
Dabigatran is an oral direct thrombin inhibitor that works by selectively binding to and inhibiting the activity of thrombin, thus preventing the conversion of fibrinogen to fibrin and subsequent clot formation. Dabigatran has a rapid onset of action and a predictable pharmacokinetic profile, making it a convenient option for oral anticoagulation. The mechanism of action of dabigatran involves the inhibition of thrombin's proteolytic activity, which is essential for the formation of blood clots.

**Why Each Wrong Option is Incorrect**
* **Option A:** Apixaban is an oral direct Factor Xa inhibitor, not a direct thrombin inhibitor. It works by inhibiting Factor Xa, a key enzyme in the coagulation cascade, but does not directly inhibit thrombin.
* **Option B:** Rivaroxaban is also an oral direct Factor Xa inhibitor, similar to apixaban. It is used for the prevention and treatment of thrombotic disorders, but its mechanism of action involves the inhibition of Factor Xa, not thrombin.
* **Option D:** Heparin is an indirect anticoagulant that works by activating antithrombin, which then inhibits thrombin and other coagulation enzymes. It is not a direct thrombin inhibitor and requires administration via intravenous or subcutaneous routes.

**Clinical Pearl / High-Yield Fact**
Direct thrombin inhibitors like dabigatran have a predictable pharmacokinetic profile, making them convenient options for oral anticoagulation. However, they require monitoring of renal function, as dabigatran is primarily excreted by the kidneys.

**Correct Answer:** C. Dabigatran